Literature DB >> 8070611

A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.

M F Saad1, R L Anderson, A Laws, R M Watanabe, W W Kades, Y D Chen, R E Sands, D Pei, P J Savage, R N Bergman.   

Abstract

An insulin-modified frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis was compared with the glucose clamp in 11 subjects with normal glucose tolerance (NGT), 20 with impaired glucose tolerance (IGT), and 24 with non-insulin-dependent diabetes mellitus (NIDDM). The insulin sensitivity index (SI) was calculated from FSIGTT using 22- and 12-sample protocols (SI(22) and SI(12), respectively). Insulin sensitivity from the clamp was expressed as SI(clamp) and SIP(clamp). Minimal model parameters were similar when calculated with SI(22) and SI(12). SI could not be distinguished from 0 in approximately 50% of diabetic patients with either protocol. SI(22) correlated significantly with SI(clamp) in the whole group (r = 0.62), and in the NGT (r = 0.53), IGT (r = 0.48), and NIDDM (r = 0.41) groups (P < 0.05 for each). SI(12) correlated significantly with SI(clamp) in the whole group (r = 0.55, P < 0.001) and in the NGT (r = 0.53, P = 0.046) and IGT (r = 0.58, P = 0.008) but not NIDDM (r = 0.30, P = 0.085) groups. When SI(22), SI(clamp), and SIP(clamp) were expressed in the same units, SI(22) was 66 +/- 5% (mean +/- SE) and 50 +/- 8% lower than SI(clamp) and SIP(clamp), respectively. Thus, minimal model analysis of the insulin-modified FSIGTT provides estimates of insulin sensitivity that correlate significantly with those from the glucose clamp. The correlation was weaker, however, in NIDDM. The insulin-modified FSIGTT can be used as a simple test for assessment of insulin sensitivity in population studies involving nondiabetic subjects. Additional studies are needed before using this test routinely in patients with NIDDM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070611     DOI: 10.2337/diab.43.9.1114

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  66 in total

1.  Effects of etanercept in patients with the metabolic syndrome.

Authors:  L Elizabeth Bernstein; Jacqueline Berry; Sunnie Kim; Bridget Canavan; Steven K Grinspoon
Journal:  Arch Intern Med       Date:  2006-04-24

Review 2.  Comparison of equivalence and determination of diagnostic utility of min-mod and clamp methods for insulin resistance in diabetes free subjects: a meta-analysis.

Authors:  Antonio Gordillo-Moscoso; J Francisco Valadéz-Castillo; Peter B Mandeville; J Francisco Hernández-Sierra
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

3.  Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover.

Authors:  E B Marliss; S Chevalier; R Gougeon; J A Morais; M Lamarche; O A J Adegoke; G Wu
Journal:  Diabetologia       Date:  2005-12-21       Impact factor: 10.122

4.  Is the minimal model too minimal?

Authors:  A Caumo; P Vicini; C Cobelli
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

Review 5.  Insulin resistance in HIV-related lipodystrophy.

Authors:  Nasser Mikhail
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

6.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Caloric restriction with or without exercise: the fitness versus fatness debate.

Authors:  D Enette Larson-Meyer; Leanne Redman; Leonie K Heilbronn; Corby K Martin; Eric Ravussin
Journal:  Med Sci Sports Exerc       Date:  2010-01       Impact factor: 5.411

8.  Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study.

Authors:  N D Palmer; C D Langefeld; J T Ziegler; F Hsu; S M Haffner; T Fingerlin; J M Norris; Y I Chen; S S Rich; T Haritunians; K D Taylor; R N Bergman; J I Rotter; D W Bowden
Journal:  Diabetologia       Date:  2009-11-10       Impact factor: 10.122

9.  Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent.

Authors:  Yi Zhang; Gabriele E Sonnenberg; Tesfaye Mersha Baye; Jack Littrell; Jennifer Gunnell; Ann DeLaForest; Erin MacKinney; Cecilia J Hillard; Ahmed H Kissebah; Michael Olivier; Russell A Wilke
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

10.  Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents.

Authors:  Sun H Kim; Lilla Nikolics; Fahim Abbasi; Cindy Lamendola; James Link; Gerald M Reaven; Steven Lindley
Journal:  J Psychiatr Res       Date:  2009-12-03       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.